Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Select category
Search this blog
Why you need the Right Drug Trial Participants: GERD
Posted on October 24th, 2016 by Patricia Morgan in Pharma R&D
Gastroesophageal reflux disease (GERD) is best conceptualized as a complex constellation of related syndromes rather than a single disease entity. People tend to lump the various symptoms of GERD together, when in fact the various facets of GERD, such as esophagitis, symptomatic regurgitation, and reflex cough, represent variegate pathology. Continue reading “Why you need the Right Drug Trial Participants: GERD” »
